CORT CORCEPT THERAPEUTICS INC
Last updated: Nov 16, 2026
Execution Consistency
Did the company actually spend money buying back stock in 3+ of the last 4 quarters?
Bought back stock in 4/4 quarters. Q3 2026: $42M, Q2 2026: $103M, Q1 2026: $27M, Q3 2025: $12M
Execution Acceleration
Is the most recent quarter's buyback spend more than 15% above the trailing average?
Latest quarter $42M vs trailing avg $47M (-10%)
Buyback vs FCF
What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.
Buyback $185M / FCF $4M = 4217% of FCF
Buyback Intensity
How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.
Repurchased 30,800,000 shares = 36.4% of 112,710,000 outstanding (annualized)
Insider Buying
Are officers and directors buying stock with their own money on the open market?
2 open-market purchases by 1 insiders
- BAKER G LEONARD JR () bought 75,782 shares at $33.00 on 2026-03-17
- BAKER G LEONARD JR () bought 24,218 shares at $33.56 on 2026-03-17
Insider-Buyback Convergence
Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.
Company buybacks in 4 quarters and 2 insider purchases by 1 insiders (no calendar overlap, but both independently active)
Insider Net Direction
Over the last 90 days, are insiders net buyers or net sellers on the open market?
Insiders bought $0M, sold $43M in the last 90 days (net selling)
Red Flag
Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.
Company buying back stock while insiders sold 29.5x more than bought. 5 C-suite officers among sellers
- Vieira Roberto Wandenkolk (President, Oncology) sold 6,657 shares on 2026-11-02
- Vieira Roberto Wandenkolk (President, Oncology) sold 1,676 shares on 2026-11-02
- Vieira Roberto Wandenkolk (President, Oncology) sold 1,100 shares on 2026-10-02
- Vieira Roberto Wandenkolk (President, Oncology) sold 2,086 shares on 2026-10-02
- Vieira Roberto Wandenkolk (President, Oncology) sold 5,147 shares on 2026-10-02
- Vieira Roberto Wandenkolk (President, Oncology) sold 296 shares on 2026-09-16
- Vieira Roberto Wandenkolk (President, Oncology) sold 23,600 shares on 2026-09-02
- Vieira Roberto Wandenkolk (President, Oncology) sold 23,770 shares on 2026-09-02
- Vieira Roberto Wandenkolk (President, Oncology) sold 1,537 shares on 2026-09-02
- Vieira Roberto Wandenkolk (President, Oncology) sold 974 shares on 2026-09-02